Rare diseases
Investigational molecules
Locations
Plaza del Dr. Robert, 5., 08221 Terrassa, Spain
Hospital Universitario Mutua Terrassa in Terrassa, Spain specialises in clinical trials of conditions such as Plasma cell myeloma, Plasma cell myeloma refractory, Acute myeloid leukaemia, Bacterial infection, and other specialisations. This site conducts important research.
The medical center is at the forefront of cardiovascular medicine, focusing on innovative approaches to manage and treat heart-related conditions. The center's research is particularly concentrated on the prevention and management of atrial fibrillation, especially in patients who have undergone noncardiac surgery.
Through its research, the center aims to enhance the understanding of the effects of anticoagulation therapy in reducing the risk of stroke and other vascular complications in this patient population.
Clinical trials currently enrolling participants at this site.
Phase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
SpainINCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
SpainA Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
SpainA study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma
SpainA Study Comparing Two Treatment Schedules of Venetoclax and Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia Not Suitable for Intensive Treatment
SpainA study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands
SpainStudy on Continuous vs. Intermittent Infusion of Ampicillin and Ceftriaxone for Patients with Enterococcus faecalis Infective Endocarditis
SpainStudy Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
SpainStudy on Apixaban and Edoxaban for Preventing Stroke in Patients with Recent Perioperative Atrial Fibrillation After Noncardiac Surgery
SpainStudy Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy
SpainShort-Acting Pasireotide Test to Predict Treatment Response in Patients with Acromegaly
SpainA Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
